If you’ve been reading Avril’s blog for a while you’ll know that the Herceptin she is receiving is just one of many Monoclonal Antibodies or MABs.
Below is a very interesting podcast with Professor Jim Al-Khalili (a renowned professor at the local University of Surrey, Guildford) interviewing Sir Gregory Winter, winner of the 2018 Nobel Prize for Chemistry.
He tells Jim very modestly the fascinating story of how he invented this new class of drugs – incredibly, the market for MABs, which includes Humira for rheumatoid arthritis and Herceptin for breast cancer, was worth US$70 billion in 2018 (and that’s a LOT of dollars!). The podcast is completely non-technical and very easy to listen to.
Many thanks to Jackie for drawing this podcast to our attention.
